# Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

> **NCT03626727** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Hypersomnia
- Narcolepsy
- Traumatic Brain Injury

## Interventions

- **DRUG:** Sodium Oxybate Oral Solution [Xyrem]

## Key facts

- **NCT ID:** NCT03626727
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Target study population was extremely difficult to recruit and planned study budget was exceeded
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03626727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03626727, "Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03626727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*